Keywords: pharming, completes, ph, ii, study, pompe, disease

Pharming completes Ph II study in Pompe's disease

Article | 04 November 1999

Pharming of the Netherlands has completed its Phase II study ofhuman alpha glucosidase in infants with Pompe's disease, and reports ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in